Research library / Resveratrol and sirtuins
CC Small or few human trials. Promising, not proven. How we grade →RCT · 45 postmenopausal women randomized (15 resveratrol, 14 placebo analyzed)
Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance
J Yoshino, C Conte, L Fontana, B Mittendorfer, S Imai, K Schechtman et al. Cell Metabolism. 2012.
- In plain language
- 75 mg of resveratrol a day for 12 weeks raised blood resveratrol but did not change insulin sensitivity on the clamp test, body composition, metabolic rate, lipids, inflammatory markers or SIRT1 and AMPK in muscle and fat.
- Limits
- Small, low dose, healthy women only. Funded by NIH, DSM and the Longer Life Foundation; DSM supplied resVida, one author was a DSM employee, another advised Sirtris.
- Which of our grades it feeds
- DD Mostly mechanistic or early data. Shown openly. How we grade →Science summary: Resveratrol: mice, lifespan and people
- Source
- doi.org/10.1016/j.cmet.2012.09.015 · PubMed 23102619 · Free full text
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.